Antimicrobial Agents and Chemotherapy · 1995 · 26 citations · 6 references
PharmacyPharmacokineticsPharmacologyBioavailabilityBiopharmaceuticsClinical PharmacologyDrug DispositionPharmacokinetics Of AntimicrobialsArea Under The Concentration - Time CurveConcentration-time Curve CharacterizationDiabetic Gastroparesis TreatmentGastroparesis PharmacotherapyPharmacokinetic Absorption ParametersPharmacokinetic Parameter AnalysisPharmacokinetic ParametersPharmacokinetics Of Antimicrobial Agents
The purpose of this study was to assess the pharmacokinetic profile of ciprofloxacin in 12 patients with diabetic gastroparesis. Patients received both a single 500-mg oral (p.o.) dose and a single 400-mg intravenous (i.v.) dose of ciprofloxacin separated by a 1-week washout period. Pharmacokinetic parameters (means +/- standard deviations) for the p.o. and i.v. doses were as follows: areas under the concentration-time curve from 0 h to infinity, 9.74 +/- 2.59 and 11.78 +/- 3.18 micrograms.h/ml, respectively; maximum concentrations of drug in serum, 2.13 +/- 0.67 and 4.21 +/- 1.07 micrograms/ml, respectively; and half-lives, 4.03 +/- 0.58 and 4.20 +/- 0.58 h, respectively. The ratio of the areas under the concentration-time curves from 0 h to infinity for the p.o. and i.v. doses was 0.84, with a 90% confidence interval of 0.68 to 0.98; the mean absolute bioavailability was calculated to be 67% (range, 43 to 82%). From these data it appears that ciprofloxacin is adequately absorbed in patients with diabetic gastroparesis.
6
David J. Greenblatt, Jan Koch‐Weser · New England Journal of Medicine · 1975 · 434 citations
Abnormal Gastric Function in Longstanding, Insulin-Dependent Diabetic Patients
Mark Feldman, Desmond B. Corbett, Edward J. Ramsey et al. · Gastroenterology · 1979 · 131 citations · Full text
Medicine, Endocrinology, Physiology +13